Pharmacies - Central Asia

Central Asia

The Pharmacies market in Central Asia is anticipated to witness significant growth in the coming years.
According to projections, the revenue in this market is expected to reach US$3.84bn in 2024.
Furthermore, it is estimated that the market will experience a compound annual growth rate (CAGR) of 3.63% between 2024 and 2029, resulting in a market volume of US$4.59bn by 2029.
When compared to other countries globally, United States is expected to generate the highest revenue in the Pharmacies market, reaching US$387.30bn in 2024.
This indicates the dominant position of the United States in this market.
In terms of per capita revenue, in Central Asia is projected to generate US$48.39 per person in 2024.
This figure illustrates the amount of revenue generated per individual in the region.
In Central Asia, pharmacies are increasingly focusing on providing holistic and traditional medicine options to meet the cultural preferences of the population.

Key regions: United States, China, Germany, Japan, Europe

Market

Region

Region comparison

Currency

Analyst Opinion

The Pharmacies market in Central Asia is experiencing significant growth, driven by several key factors.

Customer preferences: Customers in Central Asia have shown a growing preference for accessible and convenient healthcare services, including pharmacies. Pharmacies provide a range of over-the-counter medications, health and wellness products, and prescription drugs, making them a one-stop-shop for many healthcare needs. Additionally, customers appreciate the expertise and advice offered by pharmacists, who can provide guidance on medication usage and potential drug interactions.

Trends in the market: One of the key trends in the Pharmacies market in Central Asia is the increasing demand for generic medications. Generic drugs are more affordable than their branded counterparts, making them a popular choice for cost-conscious customers. This trend is driven by the rising healthcare costs and the need to make healthcare more accessible to a larger population. Pharmacies are responding to this trend by expanding their range of generic medications and promoting their affordability and effectiveness. Another trend in the market is the growing focus on preventive healthcare. Customers are becoming more proactive in managing their health and are seeking products and services that can help them prevent illnesses and maintain overall wellness. Pharmacies are capitalizing on this trend by offering a wide range of vitamins, supplements, and health monitoring devices. They are also providing services such as health screenings and consultations to help customers take a proactive approach to their health.

Local special circumstances: Central Asia is a region with a large rural population and limited access to healthcare facilities. Pharmacies play a crucial role in bridging this gap by providing essential healthcare services in remote areas. They serve as a primary point of contact for individuals seeking medical advice and treatment, especially in areas where hospitals and clinics are scarce. Pharmacies in these regions often have extended operating hours to cater to the needs of the local population.

Underlying macroeconomic factors: The Pharmacies market in Central Asia is also influenced by underlying macroeconomic factors. Economic growth in the region has led to an increase in disposable income, allowing more people to afford healthcare products and services. Additionally, the aging population in Central Asia is driving the demand for healthcare services, including medications and wellness products. As the population continues to age, the demand for pharmacies is expected to grow further. In conclusion, the Pharmacies market in Central Asia is developing due to customer preferences for accessible healthcare services, including pharmacies. The market is witnessing trends such as the increasing demand for generic medications and a focus on preventive healthcare. Pharmacies in Central Asia also play a crucial role in providing healthcare services in remote areas. The underlying macroeconomic factors, such as economic growth and an aging population, are contributing to the growth of the market.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.